Michael J. Reardon, MD

Allison Family Distinguished Chair of Cardiovascular Research, Department of Cardiovascular Surgery
Professor of Cardiovascular Surgery, Institute for Academic Medicine
Full Member, Research Institute
Houston Methodist
Weill Cornell Medical College


Biography

Dr. Michael J. Reardon is a native Houstonian who attended Baylor College of Medicine where he graduated with honors and as a member of AOA. He did his general surgery residency under Dr. Michael DeBakey and cardiothoracic residency under Dr. Denton Cooley. He joined the staff of the Houston Methodist Hospital in 1985 and ran a private practice until 1993. He then joined the full time faculty of BCM rising to Professor of Surgery with tenure, Chief of Cardiothoracic Surgery and Director of the thoracic residency program. He subsequently joined the academic group at the HMH as Professor of Cardiothoracic Surgery and Chief of Cardiac Surgery.

His interests have centered on aortic surgery, cardiac valve surgery and cardiac tumors. His recent research and clinical interests have focused on minimally invasive, catheter-based approaches to these areas. He serves on the national steering committee for the CoreValve, SurTAVI and reprise III TAVR trials and as national surgical PI on the SurTAVI trial, reprise III trial and the Gore type A dissection trial. Dr. Reardon also serves as the international surgical PI for the Reprise III trial.

He holds the position of Clinical Professor of Cardiothoracic Surgery at MD Anderson Cancer Center and created the multi-institution, multidisciplinary cardiac tumor team with HMH and MDA. He has operated on more primary cardiac sarcomas than any other surgeon globally and written extensively on this topic. Dr. Reardon's group recently published the largest series of surgically treated primary cardiac sarcomas in the world. Surgical Treatment of Primary Cardiac Sarcomas: Review of a Single-Institution Experience PMID 26476808

He has served as elected president of the medical staff for the HMH and received numerous awards including the Overstreet Award and Noon Award. He currently holds the Allison Family Distinguished Chair of Cardiovascular Research and is divides his time between building innovative clinical, research and educational programs.

Description of Research

He has been the principal and co-investigator on several industry and government-sponsored clinical trials and research initiatives, and he is currently on the national steering and screening committees for the Medtronic CoreValve US Pivotal Trial and the international steering committee for the SurTAVI Trial, for which he is also a national surgical principal investigator. His research interests include cardiac tumor treatment, catheter based approaches to structural heart disease, catheter based and open aortic disease treatment Having published more than 300 articles and abstracts, Dr. Reardon conducts peer reviews for publications such as the Annals of Thoracic Surgery and Circulation and is the associate editor of surgery for the Methodist DeBakey Cardiovascular Journal.

Areas Of Expertise

Cardiac tumor treatment Catheter based approaches to structural heart disease Catheter based and open aortic disease treatments Cardiac valve disease Aortic surgery Cardiac tumor surgery Complex cardiac surgery
Education & Training

MD, Baylor College of Medicine
Residency, Baylor College of Medicine
Certificate, Healthcare Management, Rice University
Fellow, Harvard University Alley-Sheridan School of Government
Residency, Texas Heart Institute
Active Clinical Trials

PERIGON Pivotal Trial

NCT02088554


CoreValve High Risk Surgical Patients

NCT01240902

Publications

Minimally Invasive Surgical Aortic Valve Replacement Through a Right Anterior Thoracotomy: How I Teach It
Ramchandani, MK, Wyler von Ballmoos, MC & Reardon, MJ 2019, Annals of Thoracic Surgery, vol. 107, no. 1, pp. 19-23. https://doi.org/10.1016/j.athoracsur.2018.11.006

Balloon Predilation in Transcatheter Aortic Valve Replacement with Self-expanding Valves
Rehman, H, Kalra, A, Cochran, JM, Peterson, L, Khera, S, Puri, R, Kolte, D, Gupta, T, Attizzani, GF, Bhatt, DL, Barker, CM, Reardon, MJ & Kleiman, NS 2018, Structural Heart, pp. 1-7. https://doi.org/10.1080/24748706.2018.1549763

Build the Wall of Evidence
Reardon, MJ & Barker, CM 2018, Journal of the American College of Cardiology, vol. 72, no. 23, pp. 2868-2869. https://doi.org/10.1016/j.jacc.2018.09.056

5-Year Outcomes of Self-Expanding Transcatheter Versus Surgical Aortic Valve Replacement in High-Risk Patients
CoreValve U.S. Pivotal High Risk Trial Clinical Investigators 2018, Journal of the American College of Cardiology, vol. 72, no. 22, pp. 2687-2696. https://doi.org/10.1016/j.jacc.2018.08.2146

Surgery for Tumors of the Heart
Yanagawa, B, Mazine, A, Chan, EY, Barker, CM, Gritti, M, Reul, RM, Ravi, V, Ibarra, S, Shapira, OM, Cusimano, RJ & Reardon, MJ 2018, Seminars in Thoracic and Cardiovascular Surgery, vol. 30, no. 4, pp. 385-397. https://doi.org/10.1053/j.semtcvs.2018.09.001

Effect of Baseline Aortic Regurgitation on Mortality in Patients Treated With Transcatheter or Surgical Aortic Valve Replacement (from the CoreValve US Pivotal Trial)
Grayburn, PA, Oh, JK, Reardon, MJ, Popma, JJ, Deeb, GM, Boulware, M, Huang, J & Stoler, RC 2018, American Journal of Cardiology, vol. 122, no. 9, pp. 1527-1535. https://doi.org/10.1016/j.amjcard.2018.07.018

Complexities of transcatheter mitral valve replacement (TMVR) and why it is not transcatheter aortic valve replacement (TAVR)
von Ballmoos, MCW, Kalra, A & Reardon, MJ 2018, Annals of Cardiothoracic Surgery, vol. 7, no. 6, pp. 724-730. https://doi.org/10.21037/acs.2018.10.06

Neurological Complications After Transcatheter Versus Surgical Aortic Valve Replacement in Intermediate-Risk Patients
Durko, AP, Reardon, MJ, Kleiman, NS, Popma, JJ, Van Mieghem, NM, Gleason, TG, Bajwa, T, OHair, D, Brown, DL, Ryan, WH, Chang, Y, De Leon, SD & Kappetein, AP 2018, Journal of the American College of Cardiology, vol. 72, no. 18, pp. 2109-2119. https://doi.org/10.1016/j.jacc.2018.07.093

One-year outcomes of patients with severe aortic stenosis and an STS PROM of less than three percent in the SURTAVI trial
Serruys, PW, Modolo, R, Reardon, M, Miyazaki, Y, Windecker, S, Popma, J, Chang, Y, Kleiman, NS, Lilly, S, Amrane, H, Boonstra, PW, Kappetein, AP, Onuma, Y, Søndergaard, L & Van Mieghem, N 2018, EuroIntervention, vol. 14, no. 8, pp. 877-883. https://doi.org/10.4244/EIJ-D-18-00460

Does Orientation Matter?
Kleiman, NS & Reardon, MJ 2018, JACC: Cardiovascular Interventions, vol. 11, no. 17, pp. 1744-1745. https://doi.org/10.1016/j.jcin.2018.06.005

Transcatheter aortic valve replacement with the Lotus valve system
Barker, CM & Reardon, MJ 2018, Future Cardiology, vol. 14, no. 5, pp. 367-373. https://doi.org/10.2217/fca-2018-0044

Transcatheter Mitral Valve Replacement for Native and Failed Bioprosthetic Mitral Valves
Sarkar, K, Reardon, MJ, Little, SH, Barker, CM & Kleiman, NS 2018, Methodist DeBakey Cardiovascular Journal, vol. 13, no. 3, pp. 142-151. https://doi.org/10.14797/mdcj-13-3-142

Incidence, predictors and clinical outcomes of residual stenosis after aortic valve-in-valve
Bleiziffer, S, Erlebach, M, Simonato, M, Pibarot, P, Webb, J, Capek, L, Windecker, S, George, I, Sinning, J-M, Horlick, E, Napodano, M, Holzhey, DM, Petursson, P, Cerillo, A, Bonaros, N, Ferrari, E, Cohen, MG, Baquero, G, Jones, TL, Kalra, A, Reardon, MJ, Chhatriwalla, A, Gama Ribeiro, V, Alnasser, S, Van Mieghem, NM, Rustenbach, CJ, Schofer, J, Garcia, S, Zeus, T, Champagnac, D, Bekeredjian, R, Kornowski, R, Lange, R & Dvir, D 2018, Heart (British Cardiac Society), vol. 104, no. 10, pp. 828-834. https://doi.org/10.1136/heartjnl-2017-312422

Very Late Migration of Balloon-Expandable Transcatheter Aortic Valve
Kalra, A, Avenatti, E, Chinnadurai, P, Reardon, MJ, Kleiman, NS, Little, SH & Barker, CM 2018, Journal of Invasive Cardiology, vol. 30, no. 4, pp. E28-E30.

The devil is in the details
Reardon, MJ 2018, Journal of Thoracic and Cardiovascular Surgery. https://doi.org/10.1016/j.jtcvs.2018.03.025

Hemodynamic and echocardiographic comparison of the lotus and corevalve transcatheter aortic valves in patients with high and extreme surgical risk: An analysis from the REPRISE III randomized controlled trial
Asch, FM, Vannan, MA, Singh, S, Khandheria, B, Little, SH, Allocco, DJ, Meredith, IT, Feldman, TE, Reardon, MJ & Weissman, NJ 2018, Circulation, vol. 137, no. 24, pp. 2557-2567. https://doi.org/10.1161/CIRCULATIONAHA.118.034129, https://doi.org/10.1161/CIRCULATIONAHA.118.034

When to SAVR in the age of TAVR? A perspective on surgical aortic valve replacement in 2018
Wyler von Ballmoos, MC, Barker, CM, Reul, RM, Dadu, R, Ramchandani, M, Kleiman, NS & Reardon, MJ 2018, Cardiovascular Revascularization Medicine, vol. 19, no. 2, pp. 139-141. https://doi.org/10.1016/j.carrev.2018.03.014

Arguing over shadows?
Kalra, A & Reardon, MJ 2018, European Journal of Cardio-Thoracic Surgery, vol. 53, no. 2, ezx322. https://doi.org/10.1093/ejcts/ezx322

Transcatheter and Doppler waveform correlation in transcatheter aortic valve replacement
Kalra, A, Makkar, RR, Bhatt, DL, Khera, S, Kleiman, N, Reardon, MJ & Kern, MJ 2018, Open Heart, vol. 5, no. 1, e000728. https://doi.org/10.1136/openhrt-2017-000728

Standardized Definition of Structural Valve Degeneration for Surgical and Transcatheter Bioprosthetic Aortic Valves
Dvir, D, Bourguignon, T, Otto, CM, Hahn, RT, Rosenhek, R, Webb, JG, Treede, H, Sarano, ME, Feldman, T, Wijeysundera, HC, Topilsky, Y, Aupart, M, Reardon, MJ, Mackensen, GB, Szeto, WY, Kornowski, R, Gammie, JS, Yoganathan, AP, Arbel, Y, Borger, MA, Simonato, M, Reisman, M, Makkar, RR, Abizaid, A, McCabe, JM, Dahle, G, Aldea, GS, Leipsic, J, Pibarot, P, Moat, NE, Mack, MJ, Kappetein, AP, Leon, MB & VIVID (Valve in Valve International Data) Investigators 2018, Circulation, vol. 137, no. 4, pp. 388-399. https://doi.org/10.1161/CIRCULATIONAHA.117.030729